{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:00:03Z","timestamp":1791813603642,"version":"4.3.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In 2020, the Council of State and Territorial Epidemiologists (CSTE) pertussis case definition was modified; the main change was classifying polymerase chain reaction (PCR)-positive cases as confirmed, regardless of cough duration. Pertussis data reported through Enhanced Pertussis Surveillance (EPS) in 7 sites and the National Notifiable Diseases Surveillance System (NNDSS) were used to evaluate the impact of the new case definition.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We compared the number of EPS cases with cough onset in 2020 to the number that would have been reported based on the prior (2014) CSTE case definition. To assess the impact of the change nationally, the proportion of EPS cases newly reportable under the 2020 CSTE case definition was applied to 2020 NNDSS data to estimate how many additional cases were captured nationally.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 442 confirmed and probable cases reported to EPS states in 2020, 42 (9.5%) were newly reportable according to the 2020 case definition. Applying this proportion to the 6124 confirmed and probable cases reported nationally in 2020, we estimated that the new definition added 582 cases. Had the case definition not changed, reported cases in 2020 would have decreased by 70% from 2019; the observed decrease was 67%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Despite a substantial decrease in reported pertussis cases in the setting of coronavirus disease 2019 (COVID-19), our data show that the 2020 pertussis case definition change resulted in additional case reporting compared with the previous case definition, providing greater opportunities for public health interventions such as prophylaxis of close contacts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae207","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T15:26:19Z","timestamp":1712849179000},"page":"1727-1731","source":"Crossref","is-referenced-by-count":8,"title":["Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases"],"prefix":"10.1093","volume":"78","author":[{"given":"Amy B","family":"Rubis","sequence":"first","affiliation":[{"name":"Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cole","sequence":"additional","affiliation":[{"name":"Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Lucia","family":"Tondella","sequence":"additional","affiliation":[{"name":"Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia C","family":"Pawloski","sequence":"additional","affiliation":[{"name":"Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Youngkin","sequence":"additional","affiliation":[{"name":"Colorado Department of Public Health and Environment , Denver, Colorado , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Firmender","sequence":"additional","affiliation":[{"name":"Connecticut Department of Public Health , Hartford, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Aden","sequence":"additional","affiliation":[{"name":"Georgia Department of Public Health , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Cruz","sequence":"additional","affiliation":[{"name":"Minnesota Department of Public Health , St. Paul, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Stanislawski","sequence":"additional","affiliation":[{"name":"New Mexico Department of Health , Santa Fe, New Mexico , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Wester","sequence":"additional","affiliation":[{"name":"New York State Department of Public Health , Albany, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R","family":"Cieslak","sequence":"additional","affiliation":[{"name":"Oregon Health Authority , Portland, Oregon , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Acosta","sequence":"additional","affiliation":[{"name":"Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA (now with GSK Vaccines)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami H","family":"Skoff","sequence":"additional","affiliation":[{"name":"Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"2024061323564973800_ciae207-B1","author":"Centers for Disease Control and Prevention"},{"key":"2024061323564973800_ciae207-B2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.15585\/mmwr.mm6933a1","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2019","volume":"69","author":"Elam-Evans","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024061323564973800_ciae207-B3","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciy757","article-title":"The epidemiology of nationally reported pertussis in the United States, 2000\u20132016","volume":"68","author":"Skoff","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024061323564973800_ciae207-B4","author":"CDC"},{"key":"2024061323564973800_ciae207-B5"},{"key":"2024061323564973800_ciae207-B6","doi-asserted-by":"crossref","first-page":"e0195979","DOI":"10.1371\/journal.pone.0195979","article-title":"Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT)","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"2024061323564973800_ciae207-B7","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1128\/JCM.00601-11","article-title":"Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens","volume":"49","author":"Tatti","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2024061323564973800_ciae207-B8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/INF.0000000000000921","article-title":"Trends in pertussis diagnostic testing in the United States, 1990 to 2012","volume":"35","author":"Faulkner","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2024061323564973800_ciae207-B9","author":"CDC"},{"key":"2024061323564973800_ciae207-B10","volume-title":"National notifiable diseases surveillance system, 2020 annual tables of infectious disease data","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2024061323564973800_ciae207-B11","volume-title":"National notifiable diseases surveillance system, 2019 annual tables of infectious disease data","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"2024061323564973800_ciae207-B12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/infdis\/jiad028","article-title":"Changes in the incidence of invasive bacterial disease during the COVID-19 pandemic in the United States, 2014\u20132020","volume":"227","author":"Prasad","year":"2023","journal-title":"J Infect Dis"},{"key":"2024061323564973800_ciae207-B13","doi-asserted-by":"crossref","first-page":"2100933","DOI":"10.2807\/1560-7917.ES.2022.27.25.2100933","article-title":"Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020","volume":"27","author":"Matczak","year":"2022","journal-title":"Euro Surveill"},{"key":"2024061323564973800_ciae207-B14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12889-022-12830-9","article-title":"Impact of the COVID-19 pandemic on Bordetella pertussis infections in England","volume":"22","author":"Tessier","year":"2022","journal-title":"BMC Public Health"},{"key":"2024061323564973800_ciae207-B15","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.2012.14939","article-title":"Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010","volume":"308","author":"Misegades","year":"2012","journal-title":"JAMA"},{"key":"2024061323564973800_ciae207-B16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1542\/peds.2014-3358","article-title":"Tdap vaccine effectiveness in adolescents during the 2012 Washington state pertussis epidemic","volume":"135","author":"Acosta","year":"2015","journal-title":"Pediatrics"},{"key":"2024061323564973800_ciae207-B17","doi-asserted-by":"crossref","first-page":"e1047","DOI":"10.1542\/peds.2012-1928","article-title":"Waning immunity to pertussis following 5 doses of DTaP","volume":"131","author":"Tartof","year":"2013","journal-title":"Pediatrics"},{"key":"2024061323564973800_ciae207-B18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMc1212006","article-title":"Priming with whole-cell versus acellular pertussis vaccine","volume":"368","author":"Liko","year":"2013","journal-title":"N Engl J Med"},{"key":"2024061323564973800_ciae207-B19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jadohealth.2017.12.011","article-title":"Assessment of Tdap vaccination effectiveness in adolescents in integrated health-care systems","volume":"62","author":"Briere","year":"2018","journal-title":"J Adolesc Health"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae207\/57504643\/ciae207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/78\/6\/1727\/58212188\/ciae207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/78\/6\/1727\/58212188\/ciae207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T13:45:17Z","timestamp":1718372717000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/78\/6\/1727\/7644889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,4,12]]},"published-print":{"date-parts":[[2024,6,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae207","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6,15]]},"published":{"date-parts":[[2024,4,12]]}}}